Resistomycin
Based on 1 Customer Validation
Resistomycin, a pentacyclic polyketide antibiotic, possesses anticancer activity and induces apoptosis.
For research use only. We do not sell to patients.
- Purity : 99.9%
- CAS No.: 20004-62-0
- Formula: C22H16O6
- Molecular Weight:376.36
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
All Antibiotic Isoforms
More
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CCRF-CEM | IC50 |
0.5 μM
Compound: 1
|
Antiproliferative activity against human CEM cells after 72 hrs by MTT assay
Antiproliferative activity against human CEM cells after 72 hrs by MTT assay
|
[PMID: 29137865] |
| CCRF-CEM | IC50 |
0.5 μM
Compound: 5
|
Antiproliferative activity against human CEM cells assessed as growth inhibition after 72 hrs by MTT assay
Antiproliferative activity against human CEM cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 33974416] |
| HCT-116 | IC50 |
0.1 μM
Compound: 1
|
Antiproliferative activity against p53 deficient human HCT116 cells after 72 hrs by MTT assay
Antiproliferative activity against p53 deficient human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 29137865] |
| HCT-116 | IC50 |
0.3 μM
Compound: 1
|
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 29137865] |
| HeLa | IC50 |
0.1 μM
Compound: 1
|
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 29137865] |
| HeLa | IC50 |
0.1 μM
Compound: 5
|
Antiproliferative activity against human HeLa cells assessed as growth inhibition after 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 33974416] |
| HMEC-1 | IC50 |
0.5 μM
Compound: 1
|
Antiproliferative activity against HMEC1 cells after 72 hrs by MTT assay
Antiproliferative activity against HMEC1 cells after 72 hrs by MTT assay
|
[PMID: 29137865] |
| HMEC-1 | IC50 |
0.5 μM
Compound: 5
|
Cytotoxicity against human HMEC-1 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human HMEC-1 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 33974416] |
| K562 | IC50 |
0.3 μM
Compound: 1
|
Antiproliferative activity against human K562 cells after 72 hrs by MTT assay
Antiproliferative activity against human K562 cells after 72 hrs by MTT assay
|
[PMID: 29137865] |
| L1210 | IC50 |
0.7 μM
Compound: 1
|
Antiproliferative activity against mouse L1210 cells after 72 hrs by MTT assay
Antiproliferative activity against mouse L1210 cells after 72 hrs by MTT assay
|
[PMID: 29137865] |
| L1210 | IC50 |
0.7 μM
Compound: 5
|
Antiproliferative activity against mouse L1210 cells assessed as growth inhibition after 72 hrs by MTT assay
Antiproliferative activity against mouse L1210 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 33974416] |
| T-24 | IC50 |
26 μM
Compound: 1
|
Growth inhibition of human T24 cells after 72 hrs by cell impedance method
Growth inhibition of human T24 cells after 72 hrs by cell impedance method
|
[PMID: 29137865] |
In Vitro
Resistomycin attenuates triple-negative breast cancer progression by inhibiting E3 ligase Pellino-1 and inducing SNAIL/SLUG degradation[1].
Resistomycin displays a high affinity for GST-Pellino-1 (KD = 2.58 μM) as indicated by surface plasmon resonance[1].
Resistomycin treatment reduced the expression of SNAIL and SLUG in TNBC cells[1].
Resistomycin induced apoptosis and cycle arrest in human hepatocellular carcinoma cells by activating p38 MAPK pathway in vitro and in vivo[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 20004-62-0
-
Appearance Solid
-
Molecular Weight 376.36
-
Formula C22H16O6
-
Color Yellow to orange
-
SMILES
OC1=C(C(C2=C(O)C=C(C)C(C(O)=C3)=C2C4=C3C(C)(C)C5=O)=O)C4=C5C(O)=C1
-
Structure Classification
-
Initial Source
Streptomyces sulphureus
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
-
Data Sheet (248 KB)
-
SDS (557 KB)
- English - EN (557 KB)
- Français - FR (557 KB)
- Deutsch - DE (557 KB)
- Norwegian - NO (557 KB)
- Español - ES (557 KB)
- Swedish - SV (557 KB)
- Italian - IT (557 KB)
- Korean - KR (557 KB)
- Portuguese - PT (557 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)